Tony M. Chou - Jun 9, 2022 Form 4 Insider Report for Silk Road Medical Inc (SILK)

Role: Director
Signature: /s/Mhairi Jones, by power of attorney
Stock symbol: SILK
Transactions as of: Jun 9, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/13/2022, 06:25 PM
Previous filing: Jun 21, 2021
Next filing: Dec 15, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SILK	Common Stock	Award	$0	+846	+0.86%	$0.00	98.8K	Jun 9, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SILK	Option (right to buy)	Award	$0	+5.2K		$0.00	5.2K	Jun 9, 2022	Common Stock	5.2K	$36.90	Direct	F2
transaction	SILK	Option (right to buy)	Award	$0	+2.22K		$0.00	2.22K	Jun 9, 2022	Common Stock	2.22K	$36.90	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. All of the RSUs vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date.
F2	All of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date.
F3	The shares subject to the options represent cash retainer that the Reporting Person elected to receive in the form of stock options.
F4	One fourth of the shares subject to the option shall vest on each of September 5, 2022, December 5, 2022, March 5, 2023, and the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date.